Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort

MLA

Thomas Grinda, et al. “Evolution of Overall Survival and Receipt of New Therapies by Subtype among 20 446 Metastatic Breast Cancer Patients in the 2008-2017 ESME Cohort.” ESMO Open, vol. 6, no. 3, Dec. 2020. EBSCOhost, https://doi.org/10.1016/j.esmoop.2021.100114⟩.

APA

Thomas Grinda, Marc Debled, Thomas Bachelot, Magali Lacroix-Triki, Paul-Henri Cottu, Audrey Mailliez, Anne Patsouris, Lionel Uwer, Thierry Petit, Isabelle Desmoulins, M. Robain, A. Gonçalves, Etienne Brain, Florence Dalenc, D. Perol, C. Courtinard, Suzette Delaloge, Véronique Diéras, C. Levy, … Florian Clatot. (2020). Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort. ESMO Open, 6(3). https://doi.org/10.1016/j.esmoop.2021.100114⟩

Chicago

Thomas Grinda, Marc Debled, Thomas Bachelot, Magali Lacroix-Triki, Paul-Henri Cottu, Audrey Mailliez, Anne Patsouris, et al. 2020. “Evolution of Overall Survival and Receipt of New Therapies by Subtype among 20 446 Metastatic Breast Cancer Patients in the 2008-2017 ESME Cohort.” ESMO Open 6 (3). doi:10.1016/j.esmoop.2021.100114⟩.